Geographic Focus
Asia is where growth is — and where medicines are most needed next.
Southeast Asia enters 2026 with the fastest-growing major economies in the world. Rising incomes, expanding insurance coverage, and maturing healthcare infrastructure — the commercial case to invest in Asian healthcare has rarely been clearer.
Why Asia, why now
Fastest-growing economies
Vietnam >8%, Singapore 6.9%, Malaysia 6.3%, Indonesia 5.4% Q4 2025 GDP.
Capital into life sciences
Biomedical manufacturing captured 63.8% of Singapore's 2025 fixed-asset commitments.
Pharma is a standout sector
Pharmaceuticals and biomedical manufacturing posted double-digit growth in 2025.
Patient demand rising
In Vietnam, medicines and health services saw the sharpest price rises of any category (10%+).
The growth is real — but the region is not one market.
01
Heterogeneous healthcare systems
A single access framework does not transfer market to market.
02
Divergent regulatory timelines
PMDA, NMPA, MFDS, and TGA approvals rarely land together.
03
Local stakeholder dynamics
KOL engagement and prescriber behaviour break regional generalisations.
04
Cross-market coordination cost
Global, regional, and local teams often optimise for different KPIs.


How we work in region
Local insight
Market-level judgment
We bring operational experience across Asia markets - not regional averages. Each engagement draws on direct knowledge of stakeholder dynamics, access pathways, and commercial norms in the specific markets that matter to you.
Regional coordination
Cross-market sequencing
Multi-market launches require sequencing decisions that account for regulatory timelines, pricing interdependencies, and resource constraints simultaneously. We structure coordination so market-level execution can proceed without losing regional coherence.
Global alignment
Bridging global and local
Global teams set strategy; local teams execute. The translation between them is where decisions slow down or break down. We operate at that interface - ensuring the global framework enables rather than constrains local performance.
Start the conversation
Asia requires local judgment. We bring both.
If you are planning a launch, managing a multi-market access strategy, or need a sharper view of a specific market, we are the right starting point.
Book an Advisory Call
